All Stories

  1. METTL16 in cancer: Roles and regulatory mechanisms
  2. DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells
  3. Alteration of gene expression profile in CD3+ T-cells after downregulating MALT1
  4. Increased exhausted CD8+ T cells with programmed death-1, T-cell immunoglobulin and mucin-domain-containing-3 phenotype in patients with multiple myeloma
  5. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia
  6. Different aberrant expression pattern of immune checkpoint receptors in patients with PTCL and NK/T-CL
  7. A20SNP rs77191406 may be related to secondary cancer for rheumatoid arthritis and systemic lupus erythematosus patients
  8. A polymethoxyflavone from Laggera pterodonta induces apoptosis in imatinib-resistant K562R cells via activation of the intrinsic apoptosis pathway
  9. T-cell immune suppression in patients with hematologic malignancies: clinical implications
  10. Gene expression profile analysis of SUDHL6 cells with siRNA-mediatedBCL11Adownregulation
  11. Lead poisoning influences TCR-related gene expression patterns in peripheral blood T-lymphocytes of exposed workers
  12. Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia
  13. Abnormal expression of A20 and its regulated genes in peripheral blood from patients with lymphomas
  14. Merkel-like cells in the murine conjunctival stroma
  15. Alteration of the gene expression profile of T-cell receptor αβ-modified T-cells with diffuse large B-cell lymphoma specificity
  16. The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
  17. Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML
  18. The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
  19. Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation
  20. Upregulated TCRζ Enhances Interleukin-2 Production in T-Cells from Patients with CML
  21. Expression feature of CD3, FcɛRIγ, and Zap-70 in patients with chronic lymphocytic leukemia
  22. New insights into antigen specific immunotherapy for chronic myeloid leukemia
  23. The role of BCL11B in hematological malignancy
  24. The role of A20 in the pathogenesis of lymphocytic malignancy
  25. Characterization of the CDR3 structure of the Vβ21 T cell clone in patients with P210BCR-ABL-positive chronic myeloid leukemia and B-cell acute lymphoblastic leukemia
  26. The expression pattern of CD3 chain genes in fetal/maternal interface
  27. Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients
  28. Expression and distribution of PPP2R5C gene in leukemia
  29. Decreased level of recent thymic emigrants in CD4+ and CD8+T cells from CML patients
  30. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia
  31. The feature of TRGV and TRDV repertoire distribution and clonality in patients with immune thrombocytopenic purpura
  32. TCR ζ chain expression in T cells from patients with CML
  33. TRGV and TRDV repertoire distribution and clonality of T cells from umbilical cord blood
  34. Alterations in the expression pattern of TCR ζ chain in T cells from patients with hematological diseases
  35. GATA-1, -2 and -3 genes expression in bone marrow microenviroment with chronic aplastic anemia
  36. The TCR Vβ repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen
  37. Recent thymic output function in patients with hematological malignancy
  38. KDR and Sema3 genes expression in bone marrow stromal cells and hematopoietic cells from leukemia patients and normal individuals
  39. Clonal expanded TCR Vβ T cells in patients with APL
  40. Leukemia Associated Clonal Expansion of TCR Vβ Subfamily T Cells